CURE:AU ETFS S&P Biotech ETF

AUD 46.60 -0.59 -1.250265
Icon

ETFS S&P Biotech ETF (CURE:AU) Stock Analysis and Price Targets

ETF | Others | AU
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

AUD 46.60

-0.59 (-1.25)%

AUD 0.04B

700.00

AUD -1.00

N/A

Icon

CURE:AU

ETFS S&P Biotech ETF (AUD)
ETF | AU
AUD 46.60
0.00 0
Take a Tour

ETFS S&P Biotech ETF (CURE:AU) Stock Forecast

N/A

Based on the ETFS S&P Biotech ETF stock forecast from 0 analysts, the average analyst target price for ETFS S&P Biotech ETF is not available over the next 12 months. ETFS S&P Biotech ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ETFS S&P Biotech ETF is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, ETFS S&P Biotech ETF’s stock price was AUD 46.60. ETFS S&P Biotech ETF’s stock price has changed by +1.97% over the past week, +6.54% over the past month and +5.93% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...